相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Speciation of reactive sulfur species and their reactions with alkylating agents: do we have any clue about what is present inside the cell?
Virag Bogdandi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2018)
Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic
John L. Wallace et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Evaluating the Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs
Elliott M. Antman
CIRCULATION (2017)
A novel orally administered trimebutine compound (GIC-1001) is anti-nociceptive and features peripheral opioid agonistic activity and Hydrogen Sulphide-releasing capacity in mice
N. Cenac et al.
EUROPEAN JOURNAL OF PAIN (2016)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID
Rory W. Blackler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Anti-Inflammatory and Cytoprotective Actions of Hydrogen Sulfide: Translation to Therapeutics
John L. Wallace et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Hydrogen Sulfide Protects from Colitis and Restores Intestinal Microbiota Biofilm and Mucus Production
Jean-Paul Motta et al.
INFLAMMATORY BOWEL DISEASES (2015)
Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter
John L. Wallace et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota
Rory W. Blackler et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
NSAID-gastroenteropathy: new aspects of pathogenesis and prevention
Rory W. Blackler et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Polypharmacy of Osteoarthritis: The Perfect Intestinal Storm
John L. Wallace
DIGESTIVE DISEASES AND SCIENCES (2013)
Enhanced Synthesis and Diminished Degradation of Hydrogen Sulfide in Experimental Colitis: A Site-Specific, Pro-Resolution Mechanism
Kyle L. Flannigan et al.
PLOS ONE (2013)
Gas Mediators Involved in Modulating Duodenal HCO3- Secretion
K. Takeuchi et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Gastrointestinal-Sparing Effects of Novel NSAIDs in Rats with Compromised Mucosal Defence
Rory Blackler et al.
PLOS ONE (2012)
Proton Pump Inhibitors Exacerbate NSAID-Induced Small Intestinal Injury by Inducing Dysbiosis
John L. Wallace et al.
GASTROENTEROLOGY (2011)
Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)
John L. Wallace et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Treatment of osteoarthritis in hypertensive patients
Isla S. Mackenzie et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Time Trends and Impact of Upper and Lower Gastrointestinal Bleeding and Perforation in Clinical Practice
Angel Lanas et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Endogenous and Exogenous Hydrogen Sulfide Promotes Resolution of Colitis in Rats
John L. Wallace et al.
GASTROENTEROLOGY (2009)
Prostaglandins, NSAIDs, and gastric mucosal protection: Why doesn't the stomach digest itself?
John L. Wallace
PHYSIOLOGICAL REVIEWS (2008)
Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.D.) alone or coadministered with celecoxib or naproxen: A randomized, 1-week trial
Jay L. Goldstein et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis
S. Fiorucci et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Hydrogen sulfide enhances ulcer healing in rats
John L. Wallace et al.
FASEB JOURNAL (2007)
Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole
J. L. Goldstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
A randomized, double-blind, one-week study comparing effects of a novel COX-2 inhibitor and naproxen on the gastric mucosa
James B. Moberly et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor
JL Goldstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects
CH Wilder-Smith et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2006)
First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215]
Ralf H. Wittenberg et al.
ARTHRITIS RESEARCH & THERAPY (2006)
The gastrointestinal tolerability of the LOX/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: Results from a randomized, controlled trial
P Bias et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
A Randomized, Controlled Comparison of Ibuprofen at the Maximal Over-the-Counter Dose Compared With Prescription-Dose Celecoxib on Upper Gastrointestinal Mucosal Injury
James M. Scheiman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
A comparison of the upper gastrointestinal mucosal effects of valdecoxib, naproxen and placebo in healthy elderly subjects
JL Goldstein et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
